Axim Biotechnologies Stock Market Outlook
| AXIM Stock | USD 0.01 0.0002 1.43% |
About 65% of Axim Biotechnologies' investor base is looking to short. The analysis of overall sentiment of trading Axim Biotechnologies pink sheet suggests that many investors are alarmed at this time. Axim Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Axim Biotechnologies. Many technical investors use Axim Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Comfort Level 35
Alarmed
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Axim Biotechnologies' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Axim Biotechnologies.
News SentimentNeutral | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Axim Biotechnologies is 'Strong Sell'. The recommendation algorithm takes into account all of Axim Biotechnologies' available fundamental, technical, and predictive indicators you will find on this site.
Execute Axim Biotechnologies Advice
The Axim recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Axim Biotechnologies. Macroaxis does not own or have any residual interests in Axim Biotechnologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Axim Biotechnologies' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Soft | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
For the selected time horizon Axim Biotechnologies has a Mean Deviation of 9.06, Semi Deviation of 8.76, Standard Deviation of 13.64, Variance of 185.97, Downside Variance of 156.01 and Semi Variance of 76.65We provide trade advice to complement the prevailing expert consensus on Axim Biotechnologies. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Axim Biotechnologies is not overpriced, please confirm all Axim Biotechnologies fundamentals, including its price to sales, cash flow from operations, z score, as well as the relationship between the cash and equivalents and total asset . As Axim Biotechnologies appears to be a penny stock we also recommend to validate its price to book numbers.
Axim Biotechnologies Trading Alerts and Improvement Suggestions
| Axim Biotechnologies is way too risky over 90 days horizon | |
| Axim Biotechnologies has some characteristics of a very speculative penny stock | |
| Axim Biotechnologies appears to be risky and price may revert if volatility continues | |
| Axim Biotechnologies has a very high chance of going through financial distress in the upcoming years | |
| Axim Biotechnologies currently holds 5.06 M in liabilities with Debt to Equity (D/E) ratio of 1.36, which is about average as compared to similar companies. Axim Biotechnologies has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Axim Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Axim Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Axim Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Axim to invest in growth at high rates of return. When we think about Axim Biotechnologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 60.46 K. Net Loss for the year was (16.03 M) with profit before overhead, payroll, taxes, and interest of 60.46 K. | |
| Axim Biotechnologies currently holds about 65.16 K in cash with (2.49 M) of positive cash flow from operations. | |
| Roughly 41.0% of Axim Biotechnologies shares are held by company insiders |
Axim Biotechnologies Returns Distribution Density
The distribution of Axim Biotechnologies' historical returns is an attempt to chart the uncertainty of Axim Biotechnologies' future price movements. The chart of the probability distribution of Axim Biotechnologies daily returns describes the distribution of returns around its average expected value. We use Axim Biotechnologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Axim Biotechnologies returns is essential to provide solid investment analysis for Axim Biotechnologies.
| Mean Return | 1.32 | Value At Risk | -15.79 | Potential Upside | 21.43 | Standard Deviation | 13.64 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Axim Biotechnologies historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Axim Biotechnologies Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Axim Biotechnologies or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Axim Biotechnologies' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Axim pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 1.21 | |
β | Beta against Dow Jones | 1.08 | |
σ | Overall volatility | 13.91 | |
Ir | Information ratio | 0.09 |
Axim Biotechnologies Volatility Alert
Axim Biotechnologies is showing large volatility of returns over the selected time horizon. Axim Biotechnologies is a penny stock. Although Axim Biotechnologies may be in fact a good investment, many penny pink sheets are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Axim Biotechnologies. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Axim instrument if you perfectly time your entry and exit. However, remember that penny pink sheets that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Axim Biotechnologies Fundamentals Vs Peers
Comparing Axim Biotechnologies' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Axim Biotechnologies' direct or indirect competition across all of the common fundamentals between Axim Biotechnologies and the related equities. This way, we can detect undervalued stocks with similar characteristics as Axim Biotechnologies or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Axim Biotechnologies' fundamental indicators could also be used in its relative valuation, which is a method of valuing Axim Biotechnologies by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Axim Biotechnologies to competition |
| Fundamentals | Axim Biotechnologies | Peer Average |
| Return On Equity | -100.19 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Operating Margin | (847.86) % | (5.51) % |
| Current Valuation | 13.6 M | 16.62 B |
| Shares Outstanding | 186.44 M | 571.82 M |
| Shares Owned By Insiders | 40.97 % | 10.09 % |
| Price To Earning | (53.71) X | 28.72 X |
| Price To Book | 2.86 X | 9.51 X |
| Price To Sales | 943.93 X | 11.42 X |
| Revenue | 60.46 K | 9.43 B |
| Gross Profit | 60.46 K | 27.38 B |
| EBITDA | (13.42 M) | 3.9 B |
| Net Income | (16.03 M) | 570.98 M |
| Cash And Equivalents | 65.16 K | 2.7 B |
| Total Debt | 5.06 M | 5.32 B |
| Debt To Equity | 1.36 % | 48.70 % |
| Current Ratio | 0.06 X | 2.16 X |
| Book Value Per Share | (0.02) X | 1.93 K |
| Cash Flow From Operations | (2.49 M) | 971.22 M |
| Earnings Per Share | (0.13) X | 3.12 X |
| Number Of Employees | 6 | 18.84 K |
| Beta | 1.49 | -0.15 |
| Market Capitalization | 4.64 M | 19.03 B |
| Total Asset | 5.32 M | 29.47 B |
| Retained Earnings | (36.37 M) | 9.33 B |
| Working Capital | (1.36 M) | 1.48 B |
| Current Asset | 1.18 M | 9.34 B |
| Current Liabilities | 2.55 M | 7.9 B |
| Z Score | -15.0 | 8.72 |
| Net Asset | 5.32 M |
Axim Biotechnologies Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Axim . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 0.0138 | |||
| Day Typical Price | 0.0138 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0002) |
About Axim Biotechnologies Buy or Sell Advice
When is the right time to buy or sell Axim Biotechnologies? Buying financial instruments such as Axim Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Axim Biotechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recycling Thematic Idea Now
Recycling
West management companies as well as entities specializing in pollution control and recycling. The Recycling theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recycling Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.